Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
MS related employment and disease modifying treatment in the German working population: 1994-2009.
A controlled trial of natalizumab for relapsing multiple sclerosis.
Exercise and quality of life in women with multiple sclerosis.
miRNA in multiple sclerosis: search for novel biomarkers.
CD4 cell response to interval therapy with natalizumab.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
Four Square Step Test in ambulant persons with multiple sclerosis: validity, reliability, and responsiveness.
Sublime Microglia: Expanding Roles for the Guardians of the CNS.
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million
Atypical guillain-barré syndrome misdiagnosed as lumbar spinal stenosis.
Genzyme receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) application
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
Sexual dysfunction ın multiple sclerosis: Gender differences.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Central nervous system lymphoma associated with natalizumab.
Differential diagnosis for cervical spondylotic myelopathy: literature review.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.

Pages